Nushrat Bharucha confirmed as lead in Marathi horror film ‘Lapachhapi’


Nushrat Bharucha has been confirmed to play the lead in the Hindi remake of hit Marathi horror film ‘Lapachapi’.

The Hindi remake titled ‘Chhori’ and will be helmed by India’s Abundantia Entertainment and Crypt TV of the USA.

Upon confirming the news, Bharucha told a leading publication, “I am extremely excited to be a part of Chhori. This genre excites me and the fact that the story is anchored in practices of our society, makes it relatable and impactful. I have wanted to work with Vishal Furia and I am so glad we are finally getting to collaborate on Chhori, which is so close to his heart. Abundantia Entertainment and Vikram Malhotra have always backed high-quality, progressive stories and are known to make films with strong female voices and as an actor, I couldn’t ask for more. Our collaboration with an international creator like Crypt TV and its CEO Jack Davis, whose expertise in this genre is unparalleled, makes this even more thrilling. I have enjoyed some of their content thoroughly and in my very first meeting with Jack we connected instantly on how we envisaged this genre and film. I am looking forward to beginning my experience with each one of them.”

Producer Vikram Malhotra of the Abundantia Entertainment said, “I am confident that our collaboration on this film will allow us to create some irresistibly scary content under our latest vertical ‘Psych’. I am also delighted to collaborate with the immensely talented Nushrat. I have seen her grow as an artist and her dedication to her craft is amazing.”

Jack Davis, Co-Founder and CEO – Crypt TV, added, “Abundantia and Crypt share a passion for using genre as a way to tell culture-changing stories and I found the perfect mix of that and meaningful social issues in Lapachhapi. Working with an exceptional filmmaker like Vishal Furia is a privilege and key to telling such an important story in the horror genre. And to have Nushrat Bharucha playing the lead in the film is a true thrill.”

Latest From Related Articles

Leave Comment

Please enter your name here
Please enter your comment!